Is West Pharmaceutical (WST) 23.2% Undervalued After Q1 2026 Beat? Adj. EPS $2.13 vs $1.67 Est.; Revenue $844.9M vs $779.97M Est.; GF Score 93/100

On April 23, 2026, West Pharmaceutical Services Inc (WST) released its 8-K filing reporting first-quarter 2026 results. The company posted net sales of $844.9 m